GlassScriptPhysician profile
Sriram Sudarshan
NPI 1285696492
$6,421.18
in general payments reported to CMS, 2019-2025
44 companies · $775 in 2025
The $775 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,142 · 2020: $392 · 2021: $859 · 2022: $1,373 · 2023: $902 · 2024: $977 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,654.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $902.69 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $502.82 | 2019-2025 | |
| Abiomed | $500.00 | 2019-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $447.73 | 2020-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $391.05 | 2020-2023 | Farxiga |
| Amgen INC. | $324.93 | 2019-2023 | Repatha |
| Pfizer INC. | $324.22 | 2019-2022 | |
| Cvrx, INC. | $309.34 | 2024-2025 | Barostim Neo System |
| Inari Medical, INC. | $280.31 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endologix LLC | $212.70 | 2019 | |
| Heartflow, INC. | $164.27 | 2022-2023 | Ffrct |
| Janssen Pharmaceuticals, INC | $152.43 | 2021-2023 | Xarelto |
| Medtronic, INC. | $144.90 | 2023-2025 | Onyx Frontier, Ligasure |
| Cook Medical LLC | $134.08 | 2021-2022 | |
| Shockwave Medical, INC | $132.79 | 2022-2025 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $127.29 | 2020-2023 | Camzyos |
| Amarin Pharma, INC. | $114.10 | 2019-2021 | |
| Edwards Lifesciences Corporation | $111.87 | 2024 | Sapien 3 Ultra Resilia |
| Silk Road Medical, INC. | $101.40 | 2021-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Beckman Coulter, INC. | $93.11 | 2021 | |
| Philips North America LLC | $92.34 | 2022 | |
| Novo Nordisk INC | $85.08 | 2022-2024 | |
| Abbott Laboratories | $76.09 | 2019-2023 | Cardiomems |
| Medtronic Vascular, INC. | $72.44 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $67.26 | 2024 | Inpefa |
| Bolton Medical INC | $56.31 | 2024 | Treo Abdominal Stent-Graft System |
| Atricure, INC. | $55.24 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Chiesi USA, INC. | $52.07 | 2020 | |
| Sanofi-Aventis U.S. LLC | $39.56 | 2019 | |
| Inspire Medical Systems, INC. | $38.83 | 2025 | Inspire |
| Scpharmaceuticals INC. | $35.96 | 2025 | |
| Boston Scientific Corporation | $34.20 | 2022 | |
| Surmodics, INC. | $34.17 | 2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Potrero Medical, INC. | $31.68 | 2022 | |
| Baxter Healthcare | $27.63 | 2024 | Perclot |
| Corcym INC | $24.24 | 2022 | |
| Cardiovascular Systems INC. | $20.94 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.69 | 2021 | |
| Stryker Corporation | $19.61 | 2025 | Clottriever Bold Catheter |
| W. L. Gore & Associates, INC. | $19.27 | 2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Esperion Therapeutics, INC. | $18.25 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $15.61 | 2019 | |
| Elutia, INC. | $12.68 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sriram Sudarshan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.